Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

R. Suzuki, T. Hideshima, N. Mimura, J. Minami, H. Ohguchi, S. Kikuchi, Y. Yoshida, G. Gorgun, D. Cirstea, F. Cottini, J. Jakubikova, Y. T. Tai, D. Chauhan, P. G. Richardson, N. C. Munshi, T. Utsugi, K. C. Anderson

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma'. Together they form a unique fingerprint.